Duplex Molecular Assay Intended for Point-of-Care Diagnosis of Influenza A/B Virus Infection
Open Access
- 1 September 2013
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 51 (9) , 3031-3038
Abstract
Early diagnosis and management of influenza virus infection directly correlates with the effectiveness in disease control. Current molecular influenza virus tests were designed for use in diagnostic testing facilities, where sophisticated equipment and highly trained technicians are available. A longer turnaround time for the centralized testing than when testing near the sample source could delay the initiation of medical intervention, thereby reducing the efficacy of antiviral treatment. The new assay, the SAMBA ( s imple am plification- b ased a ssay) Flu duplex test, is a dipstick-based molecular assay developed to provide a simple, accurate, and cost-effective solution for the diagnosis of influenza A/B viruses intended for near-patient testing. The test presents an alternative format of influenza virus molecular testing that utilizes isothermal amplification and visual detection of nucleic acid on a test strip. The entire test procedure (extraction, amplification, and detection) is integrated into an enclosed semiautomated system. Analytically, the SAMBA Flu duplex test detects 95 and 85 copies of viral genomes for influenza A and B viruses, respectively, with no cross-reactivity observed against other common respiratory pathogens. The clinical performance was established by blind testing of 328 nasal/throat and nasopharyngeal swab specimens from the United Kingdom and Belgium and comparing the results with the quantitative reverse transcription-PCR method routinely used in two public health laboratories. The SAMBA Flu duplex test showed a clinical sensitivity and specificity of 100% and 97.9% for influenza virus A and 100% and 100% for influenza virus B. The test provides a new technology that could facilitate simple and timely identification of influenza virus infection, potentially resulting in more efficient control measures.Keywords
This publication has 36 references indexed in Scilit:
- Detection of Severe Fever with Thrombocytopenia Syndrome Virus by Reverse Transcription–Cross-Priming Amplification Coupled with Vertical Flow VisualizationJournal of Clinical Microbiology, 2012
- Evaluation of the Cepheid Xpert Flu Assay for Rapid Identification and Differentiation of Influenza A, Influenza A 2009 H1N1, and Influenza B VirusesJournal of Clinical Microbiology, 2012
- Development of Chemiluminescent Lateral Flow Assay for the Detection of Nucleic AcidsBiosensors, 2012
- Comparison of the FilmArray Respiratory Panel and Prodesse Real-Time PCR Assays for Detection of Respiratory PathogensJournal of Clinical Microbiology, 2011
- Comparison of the Luminex xTAG Respiratory Viral Panel with xTAG Respiratory Viral Panel Fast for Diagnosis of Respiratory Virus InfectionsJournal of Clinical Microbiology, 2011
- Poor Positive Accuracy of QuickVue Rapid Antigen Tests during the Influenza A (H1N1) 2009 PandemicJournal of Clinical Microbiology, 2010
- Nucleic Acid Dipstick Test for Molecular Diagnosis of Pandemic H1N1Journal of Clinical Microbiology, 2010
- Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in HumansScience, 2009
- Detection of Respiratory Viruses by Molecular MethodsClinical Microbiology Reviews, 2008
- Comparison of the Luminex xTAG Respiratory Viral Panel with In-House Nucleic Acid Amplification Tests for Diagnosis of Respiratory Virus InfectionsJournal of Clinical Microbiology, 2008